Immunotherapy | Tumor

The Impact of Immunotherapy

June 25th 2021, 6:00pm

Article

Thanks to ongoing research and clinical trials, it seems that there are always new immunotherapies emerging.

Bispecific Antibodies Wage a Two-Pronged Attack on Tumors

June 16th 2021, 3:00pm

Article

BiTE therapy could lead to better ways to target the immune system, while minimizing the chance of resistance.

Intralesional Therapies Help Bridge the Gap Between Improved Results and Less Toxicity

June 15th 2021, 3:00pm

Article

First immunotherapy, intralesional therapy, is making a comeback and producing durable remissions for a subgroup of patients with cancer.

Tecentriq Significantly Improves Survival Outcome in Patients with Early-Stage Non-Small Cell Lung Cancer

May 21st 2021, 1:00pm

Article

The data, according to an expert, show that treatment with Tecentriq could delay disease progression to an advanced stage, as well as the need for more aggressive therapy.

Immunotherapy Could 'Provide A Whole New Realm' For Patients with Myeloma

May 14th 2021, 6:00pm

Video

New advances in research around immunotherapies for patients with myeloma are on the horizon, according to an expert from the HealthTree Foundation & Myeloma Crowd.

Our Microbiome: A Reflection of Ourselves?

May 9th 2021, 3:00pm

Article

Sophisticated analyses can predict which gut microbiome profile may lead to better outcomes to immunotherapy for patients with advanced melanoma.

Follow Your Gut: Advances in Understanding Microbiomes Are Transforming Cancer Care

April 28th 2021, 6:00pm

Article

The gut microbiome plays an important role in how patients may respond to cancer treatments, and researchers are learning more about ways to alter it to benefit treatment outcomes.

Targeting a Specific Genetic Mutation May Change Treatment Landscape for Non-Small Cell Lung Cancer

April 21st 2021, 9:00pm

Article

Patients with non-small cell lung cancer and a KRAS G12C genetic mutation may benefit from treatment with an inhibitor targeting that mutation, although more research is needed to learn why more patients are not responding to the drug.

Cell-Based Therapies May ‘Level the Playing Field’ in Non-Small Cell Lung Cancer

April 20th 2021, 6:00pm

Article

Even with all the recent advances in targeted therapies and immunotherapy drugs, patients with non-small cell lung cancer still need more treatment options. Although it’s early, cell-based therapies have shown some promise, with more research underway.

Antibiotics With Keytruda May Affect Survival in Non-Small Cell Lung Cancer

April 15th 2021, 1:00pm

Article

Antibiotics, corticosteroids and proton pump inhibitors could cause negative impacts on survival in patients with non-small cell lung cancer who are receiving treatment with Keytruda.